Medpace Holdings (MEDP) Liabilities and Shareholders Equity (2015 - 2026)

Medpace Holdings has reported Liabilities and Shareholders Equity for 12 years, with the latest figure at $2.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 12.24% year-over-year to $2.1 billion; the trailing twelve-month figure through Mar 2026 stood at $7.4 billion (down 7.16% YoY), and the FY2025 full-year result was $2.0 billion, down 5.97% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $2.1 billion, up from $2.0 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $2.1 billion in Q1 2026, with the low at $1.3 billion in Q2 2022.
• Historically, Liabilities and Shareholders Equity has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 18.52% — and 2024, when it jumped 40.18%.
• Medpace Holdings' Liabilities and Shareholders Equity stood at $1.4 billion in 2022, then gained by 22.5% to $1.7 billion in 2023, then gained by 26.8% to $2.1 billion in 2024, then declined by 5.97% to $2.0 billion in 2025, then grew by 7.8% to $2.1 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $2.1 billion (Q1 2026), $2.0 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.